INVA
Innoviva, Inc.
15.12
USD
This page is just a preview of the data found in TrendSpider’s full version
Innoviva, Inc. stock is up 12.17% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 62.5% of the previous 15 December’s closed higher than November. In the last 1 Unusual Options Trades, there were 1 CALL.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 03 Nov 18:47 | 15 Mar, 2024 | 12.50 | 13 |
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma.
